Transaction in Own Shares

For immediate release

                                                                    4 June 2010

                  FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC                  

                                (the "Company")                                

                    MARKET PURCHASE OF COMPANY'S OWN SHARES                    

This notification is given, pursuant to the authority granted at a General
Meeting of the Company held on 2 March 2010 to make market purchases of the
Company's own shares up to an aggregate maximum of 6,716,138.

The Company has purchased a market total of 100,000 Ordinary shares of 25p each
in the capital of the Company today at a price of 648.90p per share. These
shares will be held in treasury.

Following this transaction and in conformity with the provisions of the
Transparency Directive, the Company hereby notifies the market that the
resultant number of Ordinary shares held by the Company in treasury is
7,842,699 and the total number of Ordinary shares that the Company has in issue
is 50,856,966, so that the total number of voting rights in the Company
following the repurchase is 43,014,267.

The figure of 43,014,267 may be used by shareholders as the denominator for the
calculation by which they may determine if they are required to notify their
interest in, or change to their interest in, the Company under the FSA's
Disclosure and Transparency Rules.

For and on behalf of

Frostrow Capital LLP

Company Secretary

For further information, please contact:

Mark Pope

Frostrow Capital LLP

Tel: [phone]